Announcement and Request for comment on Non-Substantive Changes to Three Data Collections, 82481-82483 [2020-27820]
Download as PDF
<![CDATA[
82481
Federal Register / Vol. 85, No. 244 / Friday, December 18, 2020 / Notices
medicine or osteopathy with a
preventive medicine residency program.
The PRCs conduct outcomes-oriented,
applied prevention research, on priority
public health topics using a multidisciplinary and community-engaged
approach. Partners include, but are not
limited to, state, local, and tribal health
departments, departments of education,
schools and school districts,
community-based organizations,
healthcare providers, and health
organizations. Partners collaborate with
the PRCs to assess community needs;
identify research priorities; set research
agendas; conduct research projects and
related activities such as training and
technical assistance; translate research
findings; and disseminate research
results to public health practitioners,
other researchers, and the general
public.
In 2020, CDC convened a work group
consisting of representatives from 11
PRCs to review proposed data fields in
PERS and provide feedback to CDC.
respondent is 25 hours. The total,
estimated, annualized burden for all
respondents is 650 hours. The proposed
web-based data collection system will
allow data entry during the entire year,
which will enable respondents to
distribute burden throughout each
funding year. Response burden is
estimated to decrease significantly in
years four and five, because cumulative
reporting means some sections will
require little to no editing through the
funding cycle. The average estimated
annualized burden for year three is
expected to be 32 hours whereas the
average estimated annualized burden for
years four and five is expected to be 21
hours.
OMB approval is requested for three
years, which will cover the last three
years in the current funding cycle. As
stated in the program announcement,
PRC Program recipients are required to
report data in PERS. There are no costs
to respondents other than their time.
Their feedback was used to refine the
data fields and ensure feasibility of the
data collection and reporting by PRCs.
These data will be used for program
monitoring and evaluation purposes.
CDC’s proposed information
collection plan is as follows: CDC will
use the information reported by PRCs
through PERS to identify training and
technical assistance needs, respond to
requests for information from Congress
and other sources, monitor grantees’
compliance with cooperative agreement
requirements, evaluate progress made in
achieving goals and objectives, and
inform program improvement efforts. In
addition, these monitoring data will
support CDC’s ability to describe the
impact and effectiveness of the PRC
Program.
The CDC currently funds 26 PRCs and
each center will annually report the
required information to the CDC
through PERS during years 3–5 of the
cooperative agreement. The average,
estimated annualized burden per
ESTIMATED ANNUALIZED BURDEN HOURS
Form name
PRCs .................................................
PERS ...............................................
Jeffrey M. Zirger,
Lead, Information Collection Review Office,
Office of Scientific Integrity, Office of Science,
Centers for Disease Control and Prevention.
[FR Doc. 2020–27819 Filed 12–17–20; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Announcement and Request for
comment on Non-Substantive Changes
to Three Data Collections
Centers for Disease Control and
Prevention (CDC), Department of Health
and Human Services (HHS).
ACTION: Request for comment.
AGENCY:
The Centers for Disease
Control and Prevention (CDC) in the
Department of Health and Human
Services (HHS) announces the opening
of a public docket to obtain comment on
non-substantive changes to three data
collections conducted by CDC’s
National Center for Health Statistics
(NCHS). Although CDC has already
SUMMARY:
VerDate Sep<11>2014
22:22 Dec 17, 2020
Jkt 253001
obtained approval from the Office of
Management and Budget (OMB) under
the Paperwork Reduction Act on these
non-substantive changes, CDC is
requesting public comment on these
non-substantive changes.
DATES: Electronic or written comments
must be received by February 16, 2021.
ADDRESSES: You may submit comments,
identified by Docket No. CDC–2020–
0123, by either of the following
methods.
• Federal eRulemaking Portal:
Regulations.gov. Follow the instructions
for submitting comments.
• Mail: Jeffrey M. Zirger, Information
Collection Review Office, Centers for
Disease Control and Prevention, 1600
Clifton Road NE, MS–D74, Atlanta,
Georgia 30329.
Instructions: All submissions received
must include the agency name, Docket
Number, and the OMB number
associated with the survey about which
comments are being provided. CDC will
post, without change, all relevant
comments to Regulations.gov.
Please note: Submit all comments
through the Federal eRulemaking portal
(regulations.gov) or by U.S. mail to the
PO 00000
Frm 00056
Fmt 4703
Sfmt 4703
Number of
responses per
respondent
26
Note: CDC does not accept comments by
email.
[CDC–2020–0123]
khammond on DSKJM1Z7X2PROD with NOTICES
Number of
respondents
Type of respondents
1
Average
burden per
response
(in hours)
Total burden
(in hours)
25
650
address listed above. Do not submit
comments by email.
FOR FURTHER INFORMATION CONTACT:
Jeffrey M. Zirger, Information Collection
Review Office, Centers for Disease
Control and Prevention, 1600 Clifton
Road, NE, MS–D74, Atlanta, Georgia
30329; phone: 404–639–7570; Email:
omb@cdc.gov.
With this
notice, CDC is providing public notice
regarding the addition of a small
number of COVID–19 related questions
to each of the following surveys
National Ambulatory Medical Care
Survey (NAMCS) OMB Control No.
0920–0278, National Electronic Health
Records Survey (NEHRS) OMB Control
No. 0920–1015, and National Hospital
Care Survey (NHCS) OMB Control No.
0920–0212. These new questions are
designed to provide information that is
essential to CDC’s emergency response
to the outbreak of a novel coronavirus.
Because these three OMB numbers are
associated with ongoing, long-term
collections, OMB requires that public
comments be solicited to inform any
adjustments to the wording of the
questions or modification of the specific
content of the COVID–19 related
SUPPLEMENTARY INFORMATION:
E:\FR\FM\18DEN1.SGM
18DEN1
82482
Federal Register / Vol. 85, No. 244 / Friday, December 18, 2020 / Notices
questions in future rounds of data
collections.
National Ambulatory Medical Care
Survey (NAMCS) (OMB Control No.
0920–0278, Exp. 05/31/2022)
NAMCS obtains nationally
representative estimates on the
provision of health care in physician
offices and community health centers
(CHCs).
NAMCS added a short block of
questions related to COVID–19 in both
(1) the traditional office-based Physician
Induction Interview, and (2) the
Community Health Center (CHC)
Director Induction Interview to provide
essential information on how the
pandemic affected care provided in
office based physician offices and CHCs.
The five questions (some with subquestions) added are presented below.
No one respondent would answer all
sub-questions. Since the interviewer has
gained efficiency in the response
options for the other non-COVID–19
questions, the additional five questions
will be absorbed by the current
estimated burden calculations.
Therefore, no change in burden is
expected.
khammond on DSKJM1Z7X2PROD with NOTICES
NAMCS–1 Traditional Physician
Induction Interview
Now I would like to ask you a few
questions about the coronavirus disease
(COVID–19) and the impact it had on
operations in your office and on your staff.
During the past THREE months, how often
did your office experience shortages of any
of the following personal protective
equipment due to the onset of the
coronavirus disease (COVID–19) pandemic?
Respirators or other approved facemasks
Eye protection, isolation gowns, or gloves
During the past THREE months, did your
office have the ability to test patients for
coronavirus disease (COVID–19) infection?
During the past THREE months, how often
did your office have a location where
patients could be referred to for coronavirus
disease (COVID–19) testing?
During the past THREE months, did your
office need to turn away or refer elsewhere
any patients with confirmed or presumptive
positive coronavirus disease (COVID–19)
infection?
During the past THREE months, did any of
the following clinical care providers in your
office test positive for coronavirus disease
(COVID–19) infection?
Physicians
Physician assistants
Nurse practitioners
Certified nurse-midwives
Registered nurses/licensed practical nurses
Other clinical care providers
During January and February 2020, was
your office using telemedicine or telehealth
technologies (for example, audio with video,
web videoconference) to assess, diagnose,
monitor, or treat patients?
VerDate Sep<11>2014
22:22 Dec 17, 2020
Jkt 253001
After February 2020, did your office’s use
of telemedicine or telehealth technologies to
conduct patient visits increase?
After February 2020, how much has your
office’s use of telemedicine or telehealth
technologies to conduct patient visits
increased?
After February 2020, has your office started
using telemedicine or telehealth
technologies?
Since your office started using these
technologies, how many of your patient visits
have been conducted using telemedicine or
telehealth technologies?
NAMCS–1 Community Health Center
(CHC) Respondent Induction Interview
Now I would like to ask you a few
questions about the coronavirus disease
(COVID–19) and the impact it had on
operations in your CHC and on your staff.
During the past THREE months, how often
did your center experience shortages of any
of the following personal protective
equipment due to the onset of the
coronavirus disease (COVID–19) pandemic?
Respirators or other approved facemasks
Eye protection, isolation gowns, or gloves
During the past THREE months, did your
center have the ability to test patients for
coronavirus disease (COVID–19) infection?
During the past THREE months, how often
did your center experience shortages of
coronavirus disease (COVID–19) tests for any
patients who needed testing?
During the past THREE months how often
did your center have a location where
patients could be referred to for coronavirus
disease (COVID–19) testing?
During the past THREE months, did your
center need to turn away or refer elsewhere
any patients with confirmed or presumptive
positive coronavirus disease (COVID–19)
infection?
During the past THREE months, did any of
the following clinical care providers in your
center test positive for coronavirus disease
(COVID–19) infection?
Physicians
Physician assistants
Nurse practitioners
Certified nurse-midwives
Registered nurses/licensed practical nurses
Other clinical care providers
During January and February 2020, was
your center using telemedicine or telehealth
technologies (for example, audio with video,
web videoconference) to assess, diagnose,
monitor, or treat patients?
After February 2020, did your center’s use
of telemedicine or telehealth technologies to
conduct patient visits increase?
After February 2020, how much has your
center’s use of telemedicine or telehealth
technologies to conduct patient visits
increased?
After February 2020, has your center
started using telemedicine or telehealth
technologies?
Since your center started using these
technologies, how many of your patient visits
have been conducted using telemedicine or
telehealth technologies?
National Electronic Health Records
Survey (NEHRS) (OMB Control No.
0920–1015, Exp. 12/31/2022)
PO 00000
Frm 00057
Fmt 4703
Sfmt 4703
NEHRS collects information on officebased physicians’ adoption and use of
electronic health record (EHR) systems,
practice information, patient
engagement, controlled substances
prescribing practices, use of health
information exchange (HIE), and the
documentation and burden associated
with medical record systems(which
include both paper-based and EHR
systems).
Six telemedicine technology
questions to assess the use of
telemedicine to provide clinical services
to patients in response to the COVID–19
pandemic were added to NEHRS. The
additional six questions will be
absorbed by the current estimated
burden calculations. Therefore, no
change in burden is expected.
NEHRS Questions
Does your practice use telemedicine
technology (e.g., audio, audio with video,
web videoconference) for patient visits?
1. Since January 2020, what percentage of
your patient visits were through telemedicine
technology?
2. What type(s) of telemedicine tools did
you use for patient visits?
3. What, if any, issues affected your use of
telemedicine?
4. To what extent are you able to provide
similar quality of care during telemedicine
visits as you do during in-person visits?
5. Please rate your overall satisfaction with
using telemedicine technology for patient
visits.
6. Do you plan to continue using
telemedicine visits (in addition to in-person
visits) when appropriate once the COVID–19
pandemic is over?
National Hospital Care Survey (NHCS)
(OMB Control No. 0920–0212, Exp. 03/
31/2022)
NHCS collects information on
inpatient hospital stays. The six
questions related to COVID–19 were
added to the NHCS Annual Hospital
Interview were designed to provide
insight into the impact of COVID–19 on
the operations of hospital emergency
departments (EDs) in the United States.
These questions will ask about: (1)
Shortages of COVID–19 tests, (2)
creation of outside COVID–19 screening
areas, (3) referrals for patients with
confirmed or presumptive positive
COVID–19 infection, (4) clinical care
providers at the responding hospital
testing positive for COVID–19, (5) the
number of inpatient/emergency
department ED visits for the year that
were related to confirmed COVID–19,
and (6) the number of inpatient/ED
visits for the year that were related to
presumptive positive COVID–19. The
additional data collected from these
questions only posed a minimal burden
E:\FR\FM\18DEN1.SGM
18DEN1
Federal Register / Vol. 85, No. 244 / Friday, December 18, 2020 / Notices
on respondents; and was absorbed in
the OMB burden previously approved.
NHCS Questions:
1. In the past year, did your hospital
experience shortages of coronavirus disease
(COVID–19) tests for any patients with
presumptive positive COVID–19 infection?
2. In the past year, did your hospital create
areas outside the hospital entrance to screen
patients for coronavirus disease (COVID–19)
infection?
3. In the past year, did your hospital need
to turn away or refer elsewhere any patients
with confirmed or presumptive positive
coronavirus disease (COVID–19) infection?
4. In the past year, did any of the following
clinical care providers in your hospital test
positive for coronavirus disease (COVID–19)
infection?
a. Physicians
b. Physician assistants
c. Nurse practitioners
d. Certified nurse-midwives
e. Registered nurses/licensed practical nurses
f. Other clinical care providers
5. For calendar year 2020, how many
inpatient/ED visits at your hospital were
related to CONFIRMED coronavirus disease
(COVID–19) infections, by quarter or by year?
Fill in the grid below.
6. For calendar year 2020, how many
inpatient/ED visits at your hospital were
Confirmed COVID–19 visits and how many
were Presumptive Positive COVID–19 visits
by quarter or by year?
Dated: December 14, 2020.
Jeffrey M. Zirger,
Lead, Information Collection Review Office,
Office of Scientific Integrity, Office of Science,
Centers for Disease Control and Prevention.
see the ACIP website for any updates:
https://www.cdc.gov/vaccines/acip/
index.html).
Written comments must be received
on or before December 21, 2020.
The meeting is open to the public.
FOR FURTHER INFORMATION CONTACT:
Stephanie Thomas, ACIP Committee
Management Specialist, Centers for
Disease Control and Prevention,
National Center for Immunization and
Respiratory Diseases, 1600 Clifton Road,
NE, MS–H24–8, Atlanta, GA 30329–
4027; Telephone: 404–639–8367; Email:
ACIP@cdc.gov.
The Director, Strategic Business
Initiatives Unit, Office of the Chief
Operating Officer, Centers for Disease
Control and Prevention, has been
delegated the authority to sign Federal
Register notices pertaining to
announcements of meetings and other
committee management activities, for
both the Centers for Disease Control and
Prevention and the Agency for Toxic
Substances and Disease Registry.
Kalwant Smagh,
Director, Strategic Business Initiatives Unit,
Office of the Chief Operating Officer, Centers
for Disease Control and Prevention.
[FR Doc. 2020–28090 Filed 12–16–20; 4:15 pm]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Medicare & Medicaid
Services
[FR Doc. 2020–27820 Filed 12–17–20; 8:45 am]
BILLING CODE 4163–19–P
[Document Identifier CMS–10346]
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Agency Information Collection
Activities: Submission for OMB
Review; Comment Request
Centers for Disease Control and
Prevention
[Docket No. CDC–2020–0124]
khammond on DSKJM1Z7X2PROD with NOTICES
Advisory Committee on Immunization
Practices (ACIP); Correction
Notice is hereby given of a change in
the meeting of the Advisory Committee
on Immunization Practices (ACIP);
December 18, 2020, 12:00 p.m.—6:00
p.m., EST; and December 20, 2020,
12:00 p.m.—6:00 p.m., EST (times
subject to change, see the ACIP website
for any updates: https://www.cdc.gov/
vaccines/acip/), which was
published in the Federal Register on
December 11, 2020, Volume 85, Number
239, page 80108.
The meeting dates and times should
read as follows:
DATES: The meeting will be held on
December 19—20, 2020 from 11 a.m. to
4:30 p.m., EST (times subject to change,
VerDate Sep<11>2014
22:22 Dec 17, 2020
Jkt 253001
Centers for Medicare &
Medicaid Services, Health and Human
Services (HHS).
ACTION: Notice.
AGENCY:
The Centers for Medicare &
Medicaid Services (CMS) is announcing
an opportunity for the public to
comment on CMS’ intention to collect
information from the public. Under the
Paperwork Reduction Act of 1995
(PRA), federal agencies are required to
publish notice in the Federal Register
concerning each proposed collection of
information, including each proposed
extension or reinstatement of an existing
collection of information, and to allow
a second opportunity for public
comment on the notice. Interested
persons are invited to send comments
regarding the burden estimate or any
other aspect of this collection of
information, including the necessity and
SUMMARY:
PO 00000
Frm 00058
Fmt 4703
Sfmt 4703
82483
utility of the proposed information
collection for the proper performance of
the agency’s functions, the accuracy of
the estimated burden, ways to enhance
the quality, utility, and clarity of the
information to be collected, and the use
of automated collection techniques or
other forms of information technology to
minimize the information collection
burden.
DATES: Comments on the collection(s) of
information must be received by the
OMB desk officer by January 19, 2021.
ADDRESSES: Written comments and
recommendations for the proposed
information collection should be sent
within 30 days of publication of this
notice to www.reginfo.gov/public/do/
PRAMain . Find this particular
information collection by selecting
‘‘Currently under 30-day Review—Open
for Public Comments’’ or by using the
search function.
To obtain copies of a supporting
statement and any related forms for the
proposed collection(s) summarized in
this notice, you may make your request
using one of following:
1. Access CMS’ website address at
website address at https://www.cms.gov/
Regulations-and-Guidance/Legislation/
PaperworkReductionActof1995/PRAListing.html.
2. Call the Reports Clearance Office at
(410) 786–1326.
FOR FURTHER INFORMATION CONTACT:
William Parham at (410) 786–4669.
SUPPLEMENTARY INFORMATION: Under the
Paperwork Reduction Act of 1995 (PRA)
(44 U.S.C. 3501–3520), federal agencies
must obtain approval from the Office of
Management and Budget (OMB) for each
collection of information they conduct
or sponsor. The term ‘‘collection of
information’’ is defined in 44 U.S.C.
3502(3) and 5 CFR 1320.3(c) and
includes agency requests or
requirements that members of the public
submit reports, keep records, or provide
information to a third party. Section
3506(c)(2)(A) of the PRA (44 U.S.C.
3506(c)(2)(A)) requires federal agencies
to publish a 30-day notice in the
Federal Register concerning each
proposed collection of information,
including each proposed extension or
reinstatement of an existing collection
of information, before submitting the
collection to OMB for approval. To
comply with this requirement, CMS is
publishing this notice that summarizes
the following proposed collection(s) of
information for public comment:
1. Type of Information Collection
Request: Extension without change of a
currently approved collection; Title of
Information Collection: Appeals of
Quality Bonus Payment Determinations;
E:\FR\FM\18DEN1.SGM
18DEN1
]]>Agencies
[Federal Register Volume 85, Number 244 (Friday, December 18, 2020)]
[Notices]
[Pages 82481-82483]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2020-27820]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
[CDC-2020-0123]
Announcement and Request for comment on Non-Substantive Changes
to Three Data Collections
AGENCY: Centers for Disease Control and Prevention (CDC), Department of
Health and Human Services (HHS).
ACTION: Request for comment.
-----------------------------------------------------------------------
SUMMARY: The Centers for Disease Control and Prevention (CDC) in the
Department of Health and Human Services (HHS) announces the opening of
a public docket to obtain comment on non-substantive changes to three
data collections conducted by CDC's National Center for Health
Statistics (NCHS). Although CDC has already obtained approval from the
Office of Management and Budget (OMB) under the Paperwork Reduction Act
on these non-substantive changes, CDC is requesting public comment on
these non-substantive changes.
DATES: Electronic or written comments must be received by February 16,
2021.
ADDRESSES: You may submit comments, identified by Docket No. CDC-2020-
0123, by either of the following methods.
Note: CDC does not accept comments by email.
Federal eRulemaking Portal: Regulations.gov. Follow the
instructions for submitting comments.
Mail: Jeffrey M. Zirger, Information Collection Review
Office, Centers for Disease Control and Prevention, 1600 Clifton Road
NE, MS-D74, Atlanta, Georgia 30329.
Instructions: All submissions received must include the agency
name, Docket Number, and the OMB number associated with the survey
about which comments are being provided. CDC will post, without change,
all relevant comments to Regulations.gov.
Please note: Submit all comments through the Federal eRulemaking
portal (regulations.gov) or by U.S. mail to the address listed above.
Do not submit comments by email.
FOR FURTHER INFORMATION CONTACT: Jeffrey M. Zirger, Information
Collection Review Office, Centers for Disease Control and Prevention,
1600 Clifton Road, NE, MS-D74, Atlanta, Georgia 30329; phone: 404-639-
7570; Email: [email protected].
SUPPLEMENTARY INFORMATION: With this notice, CDC is providing public
notice regarding the addition of a small number of COVID-19 related
questions to each of the following surveys National Ambulatory Medical
Care Survey (NAMCS) OMB Control No. 0920-0278, National Electronic
Health Records Survey (NEHRS) OMB Control No. 0920-1015, and National
Hospital Care Survey (NHCS) OMB Control No. 0920-0212. These new
questions are designed to provide information that is essential to
CDC's emergency response to the outbreak of a novel coronavirus.
Because these three OMB numbers are associated with ongoing, long-term
collections, OMB requires that public comments be solicited to inform
any adjustments to the wording of the questions or modification of the
specific content of the COVID-19 related
[[Page 82482]]
questions in future rounds of data collections.
National Ambulatory Medical Care Survey (NAMCS) (OMB Control No. 0920-
0278, Exp. 05/31/2022)
NAMCS obtains nationally representative estimates on the provision
of health care in physician offices and community health centers
(CHCs).
NAMCS added a short block of questions related to COVID-19 in both
(1) the traditional office-based Physician Induction Interview, and (2)
the Community Health Center (CHC) Director Induction Interview to
provide essential information on how the pandemic affected care
provided in office based physician offices and CHCs. The five questions
(some with sub-questions) added are presented below. No one respondent
would answer all sub-questions. Since the interviewer has gained
efficiency in the response options for the other non-COVID-19
questions, the additional five questions will be absorbed by the
current estimated burden calculations. Therefore, no change in burden
is expected.
NAMCS-1 Traditional Physician Induction Interview
Now I would like to ask you a few questions about the
coronavirus disease (COVID-19) and the impact it had on operations
in your office and on your staff.
During the past THREE months, how often did your office
experience shortages of any of the following personal protective
equipment due to the onset of the coronavirus disease (COVID-19)
pandemic?
Respirators or other approved facemasks
Eye protection, isolation gowns, or gloves
During the past THREE months, did your office have the ability
to test patients for coronavirus disease (COVID-19) infection?
During the past THREE months, how often did your office have a
location where patients could be referred to for coronavirus disease
(COVID-19) testing?
During the past THREE months, did your office need to turn away
or refer elsewhere any patients with confirmed or presumptive
positive coronavirus disease (COVID-19) infection?
During the past THREE months, did any of the following clinical
care providers in your office test positive for coronavirus disease
(COVID-19) infection?
Physicians
Physician assistants
Nurse practitioners
Certified nurse-midwives
Registered nurses/licensed practical nurses
Other clinical care providers
During January and February 2020, was your office using
telemedicine or telehealth technologies (for example, audio with
video, web videoconference) to assess, diagnose, monitor, or treat
patients?
After February 2020, did your office's use of telemedicine or
telehealth technologies to conduct patient visits increase?
After February 2020, how much has your office's use of
telemedicine or telehealth technologies to conduct patient visits
increased?
After February 2020, has your office started using telemedicine
or telehealth technologies?
Since your office started using these technologies, how many of
your patient visits have been conducted using telemedicine or
telehealth technologies?
NAMCS-1 Community Health Center (CHC) Respondent Induction Interview
Now I would like to ask you a few questions about the
coronavirus disease (COVID-19) and the impact it had on operations
in your CHC and on your staff.
During the past THREE months, how often did your center
experience shortages of any of the following personal protective
equipment due to the onset of the coronavirus disease (COVID-19)
pandemic?
Respirators or other approved facemasks
Eye protection, isolation gowns, or gloves
During the past THREE months, did your center have the ability
to test patients for coronavirus disease (COVID-19) infection?
During the past THREE months, how often did your center
experience shortages of coronavirus disease (COVID-19) tests for any
patients who needed testing?
During the past THREE months how often did your center have a
location where patients could be referred to for coronavirus disease
(COVID-19) testing?
During the past THREE months, did your center need to turn away
or refer elsewhere any patients with confirmed or presumptive
positive coronavirus disease (COVID-19) infection?
During the past THREE months, did any of the following clinical
care providers in your center test positive for coronavirus disease
(COVID-19) infection?
Physicians
Physician assistants
Nurse practitioners
Certified nurse-midwives
Registered nurses/licensed practical nurses
Other clinical care providers
During January and February 2020, was your center using
telemedicine or telehealth technologies (for example, audio with
video, web videoconference) to assess, diagnose, monitor, or treat
patients?
After February 2020, did your center's use of telemedicine or
telehealth technologies to conduct patient visits increase?
After February 2020, how much has your center's use of
telemedicine or telehealth technologies to conduct patient visits
increased?
After February 2020, has your center started using telemedicine
or telehealth technologies?
Since your center started using these technologies, how many of
your patient visits have been conducted using telemedicine or
telehealth technologies?
National Electronic Health Records Survey (NEHRS) (OMB Control No.
0920-1015, Exp. 12/31/2022)
NEHRS collects information on office-based physicians' adoption and
use of electronic health record (EHR) systems, practice information,
patient engagement, controlled substances prescribing practices, use of
health information exchange (HIE), and the documentation and burden
associated with medical record systems(which include both paper-based
and EHR systems).
Six telemedicine technology questions to assess the use of
telemedicine to provide clinical services to patients in response to
the COVID-19 pandemic were added to NEHRS. The additional six questions
will be absorbed by the current estimated burden calculations.
Therefore, no change in burden is expected.
NEHRS Questions
Does your practice use telemedicine technology (e.g., audio,
audio with video, web videoconference) for patient visits?
1. Since January 2020, what percentage of your patient visits
were through telemedicine technology?
2. What type(s) of telemedicine tools did you use for patient
visits?
3. What, if any, issues affected your use of telemedicine?
4. To what extent are you able to provide similar quality of
care during telemedicine visits as you do during in-person visits?
5. Please rate your overall satisfaction with using telemedicine
technology for patient visits.
6. Do you plan to continue using telemedicine visits (in
addition to in-person visits) when appropriate once the COVID-19
pandemic is over?
National Hospital Care Survey (NHCS) (OMB Control No. 0920-0212, Exp.
03/31/2022)
NHCS collects information on inpatient hospital stays. The six
questions related to COVID-19 were added to the NHCS Annual Hospital
Interview were designed to provide insight into the impact of COVID-19
on the operations of hospital emergency departments (EDs) in the United
States. These questions will ask about: (1) Shortages of COVID-19
tests, (2) creation of outside COVID-19 screening areas, (3) referrals
for patients with confirmed or presumptive positive COVID-19 infection,
(4) clinical care providers at the responding hospital testing positive
for COVID-19, (5) the number of inpatient/emergency department ED
visits for the year that were related to confirmed COVID-19, and (6)
the number of inpatient/ED visits for the year that were related to
presumptive positive COVID-19. The additional data collected from these
questions only posed a minimal burden
[[Page 82483]]
on respondents; and was absorbed in the OMB burden previously approved.
NHCS Questions:
1. In the past year, did your hospital experience shortages of
coronavirus disease (COVID-19) tests for any patients with
presumptive positive COVID-19 infection?
2. In the past year, did your hospital create areas outside the
hospital entrance to screen patients for coronavirus disease (COVID-
19) infection?
3. In the past year, did your hospital need to turn away or
refer elsewhere any patients with confirmed or presumptive positive
coronavirus disease (COVID-19) infection?
4. In the past year, did any of the following clinical care
providers in your hospital test positive for coronavirus disease
(COVID-19) infection?
a. Physicians
b. Physician assistants
c. Nurse practitioners
d. Certified nurse-midwives
e. Registered nurses/licensed practical nurses
f. Other clinical care providers
5. For calendar year 2020, how many inpatient/ED visits at your
hospital were related to CONFIRMED coronavirus disease (COVID-19)
infections, by quarter or by year? Fill in the grid below.
6. For calendar year 2020, how many inpatient/ED visits at your
hospital were Confirmed COVID-19 visits and how many were
Presumptive Positive COVID-19 visits by quarter or by year?
Dated: December 14, 2020.
Jeffrey M. Zirger,
Lead, Information Collection Review Office, Office of Scientific
Integrity, Office of Science, Centers for Disease Control and
Prevention.
[FR Doc. 2020-27820 Filed 12-17-20; 8:45 am]
BILLING CODE 4163-19-P
